ML20100L605

From kanterella
Jump to navigation Jump to search
Advisory Committee on the Medical Uses of Isotopes (ACMUI) Notice of Public Teleconference Meeting, April 30, 2020
ML20100L605
Person / Time
Issue date: 04/10/2020
From: Russell Chazell
NRC/SECY
To:
Jamerson, Kellee NMSS/MSST
References
85 FR 21273- 21274
Download: ML20100L605 (2)


Text

[7590-01-P]

NUCLEAR REGULATORY COMMISSION Advisory Committee on the Medical Uses of Isotopes: Meeting Notice AGENCY: U.S. Nuclear Regulatory Commission.

ACTION: Notice of Meeting.

SUMMARY

The U.S. Nuclear Regulatory Commission (NRC) will convene a teleconference meeting of the Advisory Committee on the Medical Uses of Isotopes (ACMUI) on April 30, 2020, to discuss the draft recommendations of the ACMUI COVID-19 Subcommittee. The ACMUI subcommittees recommendations will include its review of the impact of COVID-19 on the medical use community and potential regulatory relief measures as it relates to the medical uses of radioactive material. Meeting information, including a copy of the agenda and handouts, will be available at https://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2020.html.

The agenda and handouts may also be obtained by contacting Ms. Kellee Jamerson using the information below.

DATE: The teleconference meeting will be held on Thursday, April 30, 2020, 2:00 PM to 4:00 PM Eastern Time.

PUBLIC PARTICIPATION: Any member of the public who wishes to participate in the teleconference should contact Ms. Jamerson using the contact information below.

CONTACT INFORMATION: Kellee Jamerson, e-mail: Kellee.Jamerson@nrc.gov.

Conduct of the Meeting Dr. Robert Schleipman, ACMUI Vice Chairman, will preside over the meeting. Dr. Schleipman will conduct the meeting in a manner that will facilitate the orderly conduct of business. The following procedures apply to public participation in the meeting:

1. Persons who wish to provide a written statement should submit an electronic copy to Ms. Jamerson at the contact information listed above. All written statements must be received by April 27, 2020, three business days prior to the meeting, and must pertain to

2 the topic on the agenda for the meeting.

2. Questions and comments from members of the public will be permitted during the meeting at the discretion of the ACMUI Vice Chairman.
3. The draft transcript and meeting summary will be available on ACMUIs Web site https://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2020.html on or about June 15, 2020.

This meeting will be held in accordance with the Atomic Energy Act of 1954, as amended (primarily Section 161a); the Federal Advisory Committee Act (5 U.S.C. App); and the Commissions regulations in 10 CFR Part 7.

This meeting is being noticed in the Federal Register less than 15 calendar days due to the immediate need to receive recommendations from the ACMUI to develop and provide guidance to medical use licensees during the COVID-19 pandemic.

Date: April 10, 2020.

Russell Digitally signed by Russell Chazell Chazell Date: 2020.04.10 15:09:47 -04'00' Russell E. Chazell Advisory Committee Management Officer.